AI in Commercial Space & Aviation

China now leads the world in trials for next-gen CAR-T therapies — 82% of in vivo therapies tested in humans are由中国研发. This isn’t just a medical breakthrough; it’s a model for how AI can accelerate innovation in high-stakes industries like commercial space and aviation. The key? China’s fast-track investigator-initiated trial (IIT) pathway, which enables rapid clinical testing without prior regulatory approval. This creates a high-frequency feedback loop — the perfect training ground for AI. In aerospace, where safety and speed are both critical, could we learn from this model? What if AI systems were trained not on perfect simulations, but on real-world, high-velocity data streams? This is not about sacrificing rigor — it’s about recognizing that adaptability is a form of resilience. The source: Nature, 'China now leads the world in trials for next-gen CAR-T therapies' — https://www.nature.com/articles/d41586-026-03004-3?error=cookies_not_supported&code=fc2f2103-b3fa-4570-9b2e-89c245b185eb. How might we apply this to AI in aviation R&D? Source: https://www.nature.com/articles/d41586-026-03004-3?error=cookies_not_supported&code=fc2f2103-b3fa-4570-9b2e-89c245b185eb View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/reports/linkedin-groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request. MIT, Nvidia, Google & IBM-Trained. Cross Domain-Expert: Quantum, AI, Ethics, Sovereignty, Intelligence, Philanthropy. Solepoint Planning. VUI AI Cloud Architect. AI Certifications Development. Quant/AI Instructor. Castor Venture Club Member. Associate Broker. George Arnold Alexander III, MPA Director, ALEX Companies Associate Broker, Alexander Tiffany Southwest, LLC dba ALEX.realestate, et.al. Texas License #574878-B · Broker License #565194-BB Broker, ALEX Real Estate · North Carolina License #367733 Independent Broker, ALEX Real Estate · Colorado License #II.100112456 [email protected] · +1 713.918.9951